Alejandro A Diaz1, Carolyn E Come2, David M Mannino3, Victor Pinto-Plata2, Miguel J Divo2, Carol Bigelow4, Bartolome Celli2, George R Washko2. 1. Division of Pulmonary and Critical Care Medicine (Drs Diaz, Come, Pinto-Plata, Divo, Celli, and Washko)Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: ADiaz6@partners.org. 2. Division of Pulmonary and Critical Care Medicine (Drs Diaz, Come, Pinto-Plata, Divo, Celli, and Washko)Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 3. Division of Pulmonary, Sleep, and Critical Care Medicine, University of Kentucky College of Medicine, Lexington, KY; University of Kentucky College of Public Health, Lexington, KY. 4. Division of Biostatistics and Epidemiology, University of Massachusetts, Amherst, MA.
Abstract
BACKGROUND: Although obstructive lung disease (OLD), which includes COPD, affects all the populations, Hispanics seem to be protected against COPD development and progression. Whether this advantage translates into a survival benefit for this population is unknown. We aimed to determine the risk for OLD in Mexican Americans, the largest US Hispanic subgroup, compared with non-Hispanic whites and to assess all-cause mortality in subjects with OLD. METHODS: We assessed the relationships between Mexican American ethnicity and spirometric OLD and risk of death among 6,456 US adults aged ≥ 40 years who participated in the Third National Health and Nutritional Examination Survey Follow-up Study. We used logistic and Cox regression analyses to estimate the OR for OLD among Mexican Americans and the hazard ratio (HR) for all-cause mortality among Mexican Americans with OLD, respectively. RESULTS: After adjustment for demographic factors, socioeconomic status, and COPD risk factors, Mexican Americans had decreased odds of OLD diagnosis compared with whites (OR, 0.72 [95% CI, 0.54-0.95]). Among the 1,734 participants with OLD, 1,054 (60.8%) died during median follow-up of 12 years. In an adjusted model, Mexican Americans had no advantage in mortality from all causes (HR, 0.88 [95% CI, 0.69-1.13]). After accounting for the fact that some Mexican Americans may have moved back to Mexico and died there (thus, had no US death certificate), there was still no difference in mortality between these groups. CONCLUSIONS: Although Mexican Americans appear to have lower risk for OLD, subjects of this ethnicity with OLD do not seem to have a survival advantage.
BACKGROUND: Although obstructive lung disease (OLD), which includes COPD, affects all the populations, Hispanics seem to be protected against COPD development and progression. Whether this advantage translates into a survival benefit for this population is unknown. We aimed to determine the risk for OLD in Mexican Americans, the largest US Hispanic subgroup, compared with non-Hispanic whites and to assess all-cause mortality in subjects with OLD. METHODS: We assessed the relationships between Mexican American ethnicity and spirometric OLD and risk of death among 6,456 US adults aged ≥ 40 years who participated in the Third National Health and Nutritional Examination Survey Follow-up Study. We used logistic and Cox regression analyses to estimate the OR for OLD among Mexican Americans and the hazard ratio (HR) for all-cause mortality among Mexican Americans with OLD, respectively. RESULTS: After adjustment for demographic factors, socioeconomic status, and COPD risk factors, Mexican Americans had decreased odds of OLD diagnosis compared with whites (OR, 0.72 [95% CI, 0.54-0.95]). Among the 1,734 participants with OLD, 1,054 (60.8%) died during median follow-up of 12 years. In an adjusted model, Mexican Americans had no advantage in mortality from all causes (HR, 0.88 [95% CI, 0.69-1.13]). After accounting for the fact that some Mexican Americans may have moved back to Mexico and died there (thus, had no US death certificate), there was still no difference in mortality between these groups. CONCLUSIONS: Although Mexican Americans appear to have lower risk for OLD, subjects of this ethnicity with OLD do not seem to have a survival advantage.
Authors: Rhea Powell; Duncan Davidson; Jasmin Divers; Ani Manichaikul; J Jeffrey Carr; Robert Detrano; Eric A Hoffman; Rui Jiang; Richard A Kronmal; Kiang Liu; Naresh M Punjabi; Eyal Shahar; Karol E Watson; Jerome I Rotter; Kent D Taylor; Stephen S Rich; R Graham Barr Journal: Thorax Date: 2013-04-12 Impact factor: 9.139
Authors: Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral Journal: N Engl J Med Date: 2004-03-04 Impact factor: 91.245
Authors: Alejandro A Diaz; Farbod N Rahaghi; Tracy J Doyle; Thomas P Young; Erick S Maclean; Carlos H Martinez; Raul San José Estépar; Stefano Guerra; Yohannes Tesfaigzi; Ivan O Rosas; George R Washko; David O Wilson Journal: Chronic Obstr Pulm Dis Date: 2017-09-05
Authors: R Graham Barr; Larissa Avilés-Santa; Sonia M Davis; Tom K Aldrich; Franklyn Gonzalez; Ashley G Henderson; Robert C Kaplan; Lisa LaVange; Kiang Liu; Jose S Loredo; Eliana S Mendes; Ai Ni; Andrew Ries; Matthias Salathe; Lewis J Smith Journal: Am J Respir Crit Care Med Date: 2016-02-15 Impact factor: 21.405
Authors: Kristin M Burkart; Tamar Sofer; Stephanie J London; Ani Manichaikul; Fernando P Hartwig; Qi Yan; María Soler Artigas; Lydiana Avila; Wei Chen; Sonia Davis Thomas; Alejandro A Diaz; Ian P Hall; Bernardo L Horta; Robert C Kaplan; Cathy C Laurie; Ana M Menezes; Jean V Morrison; Elizabeth C Oelsner; Deepa Rastogi; Stephen S Rich; Manuel Soto-Quiros; Adrienne M Stilp; Martin D Tobin; Louise V Wain; Juan C Celedón; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2018-07-15 Impact factor: 30.528